Robins Kaplan LLP

Contact
Share
Info
800 LaSalle Avenue
Suite 2800
Minneapolis, MN 55402, United States
Phone: 612.349.8500
Fax: 612.339.4181
Areas Of Practice
  • Alternative Dispute Resolution (ADR)
  • Antitrust & Trade Regulation
  • Appellate Practice
  • Art, Entertainment, & Sports Law
  • Bankruptcy
  • Civil Rights
  • Class Action
  • Construction Law
  • Debtor/Creditor
  • Energy & Utilities
  • Finance & Banking
  • Government
  • Health
  • Indigenous Peoples
  • Insurance
  • Intellectual Property
  • Labor & Employment Law
  • Litigation
  • Maritime Law
  • Mergers & Acquisitions
  • Personal Injury
  • Privacy
  • Products Liability
  • Real Estate
  • Science, Computers, & Tech
  • Securities Law
  • Toxic Torts
  • Wills, Trusts, & Estate Planning
See more
Locations
Other U.S. Locations
  • California
  • Massachusetts
  • Minnesota
  • New York
  • North Dakota
  • South Dakota
Number of Attorneys
200+ Attorneys

New ANDA Cases

Federal district court cases that are filed pursuant to the Hatch-Waxman Act - This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are filed pursuant to the…more
 /  Health, Intellectual Property, Science, Computers, & Technology

Generic Launches

Abbreviated New Drug Applications and 505(b)(2) Applications - This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug…more
 /  Health, Intellectual Property, Science, Computers, & Technology

ANDA Litigation Settlements

Reported settlements in federal district court cases - This chart summarizes the case name, drug, patents-in-suit, and publicly available terms for reported settlements in federal district court cases that are filed pursuant to…more
 /  Administrative Law, Civil Procedure, Health, Intellectual Property, Science, Computers, & Technology

ANDA Approvals

New Drug Applications and 505(B)(2) Applications - This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA…more
 /  Administrative Law, Health, Intellectual Property, Science, Computers, & Technology

Boehringer Ingelheim Pharms. Inc. v. Apotex Inc.

Tradjenta® (linagliptin) - Case Name: Boehringer Ingelheim Pharms. Inc. v. Apotex Inc., Civ. No. 23-685-CFC, 2025 WL 71979 (D. Del. Jan. 10, 2025) (Connolly, J.)  Drug Product and Patent(s)-in-Suit: Tradjenta® (linagliptin);…more
 /  Health, Intellectual Property, Science, Computers, & Technology

Taiho Pharma Co. v. MSN Labs Private Ltd.

Lonsurf® (tipiracil) - Case Name: Taiho Pharma Co. v. MSN Labs Private Ltd., No. 19-2342-JLH (D. Del. Jan. 23, 2025) (Hall, J.)  Drug Product and Patent(s)-in-Suit: Lonsurf® (tipiracil); U.S. Patent No. 10,457,666 (“the ’666…more
 /  Intellectual Property

Alcon Inc. v. Padagis Israel Pharms. Ltd.

Simbrinza® (brinzolamide / brimonidine) - Case Name: Alcon Inc. v. Padagis Israel Pharms. Ltd., Civ. No. 22-1422-WCB, 2025 WL 457119 (D. Del. Feb. 5, 2025) (Bryson, C.J.)  Drug Product and Patent(s)-in-Suit:  Simbrinza®…more
 /  Health, Intellectual Property, Science, Computers, & Technology

Mallinckrodt Pharms. Ireland Ltd. v. Airgas Therapeutics LLC

INOMax® (nitric oxide) - Case Name: Mallinckrodt Pharms. Ireland Ltd. v. Airgas Therapeutics LLC, Civ. No. 22-1648-RGA, 2025 WL 472557 (D. Del. Feb. 12, 2025) (Andrews, J.)  Drug Product and Patent(s)-in-Suit: INOMax® (nitric…more
 /  Health, Intellectual Property, Science, Computers, & Technology

Vanda Pharms., Inc. v. FDA

Hetlioz® (tasimelteon) - Case Name: Vanda Pharms., Inc. v. FDA, Civ. No. 23-280 (TSC), 2025 WL 485401 (D.D.C. Feb. 13, 2025) (Chutkan, J.) Drug Product and Patent(s)-in-Suit: Hetlioz® (tasimelteon); U.S. Patent No. , a…more
 /  Health, Intellectual Property, Science, Computers, & Technology

Janssen Prods., L.P. v. EVER Valinject GmbH

Yondelis® (trabectedin) - Case Name: Janssen Prods., L.P. v. EVER Valinject GmbH, Civ. No. 24-7319, 2025 WL 639380 (N.D. Ill. Feb. 27, 2025) (Harjani, J.)  Drug Product and Patent(s)-in-Suit:  Yondelis® (trabectedin); U.S…more
 /  Health, Intellectual Property, Science, Computers, & Technology

What’s Good for the Goose is Good for the Government

Sterry v. Minnesota Department of Corrections, 8 N.W.3d 224 (Minn. 2024) places Minnesota governmental employers on the same footing as private employers for the purposes of vicarious liability. The State, cities, and counties…more
 /  Administrative Law, Civil Rights, Constitutional Law, Labor & Employment Law

Liquidia Techs., Inc. v. FDA

Yutrepia® (treprostinil inhalation powder) - Case Name: Liquidia Techs., Inc. v. FDA, No. 24-2428 (D.D.C. Feb. 27, 2025) (Kelly, J.) Drug Product and Patent(s)-in-Suit: Yutrepia® (treprostinil inhalation powder) Nature of the…more
 /  Health, Intellectual Property, Science, Computers, & Technology

In re Entresto

Entresto® (valsartan/sacubitril) - Case Name: In re Entresto, 125 F.4th 1090 (Fed. Cir. Jan. 10, 2025) (Circuit Judges Lourie, Prost, and Reyna presiding; Opinion by Lourie, C.J.) (Appeal from D. Del., Andrews, J.)  Drug Product…more
 /  Health, Intellectual Property, Science, Computers, & Technology

Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc

Bridion® (sugammadex) - Case Name: Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc., No. 2023-2254, 2025 WL 795317 (Fed. Cir. Mar. 13, 2025) (Circuit Judges Dyk, Mayer, and Reyna presiding; Opinion by Dyk, C.J.) (Appeal…more
 /  Health, Intellectual Property, Science, Computers, & Technology

Janssen Pharms., Inc. v. Mylan Labs. Ltd.

Invega Trinza® (paliperidone palmitate) - Case Name: Janssen Pharms., Inc. v. Mylan Labs. Ltd., No. 2023-2042, 2025 WL 946390 (Fed. Cir. Mar. 28, 2025) (Circuit Judges Dyk, Prost, and District Judge Goldberg presiding; Opinion…more
 /  Health, Intellectual Property, Science, Computers, & Technology
Showing 1-15 of 2730 Results
/
View per page
Page: of 182
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide